Tiapride

Modify Date: 2024-01-02 13:47:33

Tiapride Structure
Tiapride structure
Common Name Tiapride
CAS Number 51012-32-9 Molecular Weight 328.42700
Density 1.15 g/cm3 Boiling Point 498.1ºC at 760 mmHg
Molecular Formula C15H24N2O4S Melting Point 120ºC
MSDS USA Flash Point 255.1ºC

 Use of Tiapride


Tiapride, an atypical neuroleptic agent, is a selective dopamine D2-receptor antagonist with little propensity for causing catalepsy and sedation. The IC50 values of Tiapride are 1440, 45.8, >100, and 11.7 μM for D1; D2; D3; D4, respectively[1].

 Names

Name Tiapride hydrochloride
Synonym More Synonyms

 Tiapride Biological Activity

Description Tiapride, an atypical neuroleptic agent, is a selective dopamine D2-receptor antagonist with little propensity for causing catalepsy and sedation. The IC50 values of Tiapride are 1440, 45.8, >100, and 11.7 μM for D1; D2; D3; D4, respectively[1].
Related Catalog
Target

D2 Receptor:110-320 nM (IC50)

D3 Receptor:180 nM (IC50)

References

[1]. D H Peters, et al. Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs. 1994 Jun;47(6):1010-32.

[2]. T Arima, et al. Comparison of effects of tiapride and sulpiride on D-1, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes. Jpn J Pharmacol. 1986 Jul;41(3):419-23.

 Chemical & Physical Properties

Density 1.15 g/cm3
Boiling Point 498.1ºC at 760 mmHg
Melting Point 120ºC
Molecular Formula C15H24N2O4S
Molecular Weight 328.42700
Flash Point 255.1ºC
Exact Mass 328.14600
PSA 87.58000
LogP 2.82590
Storage condition 2-8°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CV4203700
CHEMICAL NAME :
Benzamide, N-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl )-
CAS REGISTRY NUMBER :
51012-32-9
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C15-H24-N2-O4-S
MOLECULAR WEIGHT :
328.47

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1197 mg/kg
SEX/DURATION :
female 38 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - uterus, cervix, vagina
REFERENCE :
THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 30,231,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
850 mg/kg
SEX/DURATION :
female 27 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders
REFERENCE :
THERAP Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946- Volume(issue)/page/year: 30,231,1975

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport
WGK Germany 2
RTECS CV4203800
HS Code 2924299090

 Customs

HS Code 2924299090
Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Articles9

More Articles
Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.

Brain 138 , 3221-37, (2015)

Polyglutamine diseases are a class of dominantly inherited neurodegenerative disorders for which there is no effective treatment. Here we provide evidence that activation of serotonergic signalling is...

German insurer finds a third of people over 65 take five or more drugs a day.

BMJ 346 , f3905, (2013)

Pharmacological treatment of tic disorders and Tourette Syndrome.

Neuropharmacology 68 , 143-9, (2013)

The present review gives an overview of current pharmacological treatment options of tic disorders and Tourette Syndrome (TS). After a short summary on phenomenology, clinical course and comorbid cond...

 Synonyms

N-[2-(Diethylamino)ethyl]-5-(methylsulfonyl)-o-anisamide hydrochloride
N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide
EINECS 256-907-9
N-(2-(Diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)benzamide
MFCD00242730